Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness analysis using real world data msbase registry comparing natalizum 1
… will the product influence the clinical pathway? Are there data that can be leveraged at launch to influence … and costs impact pricing potential? How can affirmative data (e.g., FDAMA Section 114) be generated? Pricing & …
… polycystic kidney disease (ADPKD) patients: assessment of real world effectiveness of tolvaptan. Perrone RD, Nunna S, Gandhi …
… into a dichotomy, based on the P-value. This statistical analysis process fosters misinterpretation of results stemming from the mixing of two essential data descriptors - effect size and precision - into a single … insightful and reliable approaches to quantitative data analysis in epidemiological research. Join us for this …
… equity in research. Read the other two articles here. Part 1: What Factors Influence Health Equity - or Inequity? Part … Health Inequities Now With RTI Rarity™ Around the world, there is growing awareness of the pervasive health … costs, and lost workforce productivity. But by having a data-driven understanding of existing health disparities and …
… and longitudinal data sources Decision-analytic models (cost effectiveness, budget impact, Markov) Economic burden of … quality-of-life analyses Literature reviews Meta-analysis studies Patient-reported outcomes (PRO) studies …
Identifying Psychosis in Patients with Dementia Identifying Psychosis in Patients with Dementia: Not a Hallucination or Delusion, the Challenge Really Exists Joan Forns , J Bradley Layton , and Mary E Ritchey Transcript: Psychosis is a common …
… for Population Therapeutics Conference. Updated cost-utility and public health impact of recombinant zoster … J, Hicks K, Loukov D, Kaan I, Ng C, Regan J, Giannelos N. Cost-effectiveness and public health impact of recombinant zoster …
… Webinar: Common Challenges & Solutions in Analysis of PROs in Oncology Clinical Trials Share on: … analyzing, and interpreting patient-reported outcome (PRO) data for oncology trials can present unique challenges. Join … You’ll learn: The specific challenges associated with data analysis from cancer studies. Why safety and patient-reported …
… pharmacoepidemiology studies, developing protocols and analysis plans, statistical data analysis and interpretation, … institutes in Canada, where she worked with a variety of real-world data sources to conduct observational studies and … Additionally, Dr. Khan has expertise developing and using neighborhood-level measures of social determinants of …
… standard statistical threshold for determining therapeutic effectiveness in clinical trials may be too conservative and … bringing more therapies to more patients faster and more cost-effectively. This project marks the first time MDIC has … access to cutting-edge medical technology while reducing cost and time to market. For more information, visit …